R406 is a SYK inhibitor that induces apoptosis in the majority of DLBCL cell lines studied by the inhibition of both tonic and induced BCR signaling [53]; however, it also inhibits other kinases [89]. This evidence concerns the gene BCR and diffuse large B-cell lymphoma.